ASPIRIN; OXYCODONE HYDROCHLORIDE - Generic Drug Details

What are the generic sources for aspirin; oxycodone hydrochloride and what is the scope of freedom to operate?

Aspirin; oxycodone hydrochloride is the generic ingredient in six branded drugs marketed by Actavis Labs Fl Inc, Dr Reddys Labs Sa, Epic Pharma Llc, Endo Operations, Halsey, Ani Pharms, Sun Pharm Industries, and Roxane, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for ASPIRIN; OXYCODONE HYDROCHLORIDE

US Patents:	0
Tradenames:	6
Applicants:	8
NDAs:	10
Finished Product Suppliers / Packagers:	1
Clinical Trials:	6
DailyMed Link:	ASPIRIN; OXYCODONE HYDROCHLORIDE at DailyMed

Recent Clinical Trials for ASPIRIN; OXYCODONE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of North Carolina, Chapel Hill	Phase 4
Albany Medical College	Phase 4
Roche Pharma AG	Phase 1

See all ASPIRIN; OXYCODONE HYDROCHLORIDE clinical trials

Pharmacology for ASPIRIN; OXYCODONE HYDROCHLORIDE

Drug Class	Nonsteroidal Anti-inflammatory Drug Opioid Agonist Platelet Aggregation Inhibitor
Mechanism of Action	Cyclooxygenase Inhibitors Full Opioid Agonists
Physiological Effect	Decreased Platelet Aggregation Decreased Prostaglandin Production

Anatomical Therapeutic Chemical (ATC) Classes for ASPIRIN; OXYCODONE HYDROCHLORIDE

N02AA	Natural opium alkaloids
N02A	OPIOIDS
N02	ANALGESICS
N	Nervous system

US Patents and Regulatory Information for ASPIRIN; OXYCODONE HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Endo Operations	PERCODAN	aspirin; oxycodone hydrochloride	TABLET;ORAL	007337-007	Aug 5, 2005	AA	RX	Yes	Yes
Halsey	CODOXY	aspirin; oxycodone hydrochloride; oxycodone terephthalate	TABLET;ORAL	087464-001	Jul 1, 1982		DISCN	No	No
Actavis Labs Fl Inc	OXYCODONE AND ASPIRIN	aspirin; oxycodone hydrochloride	TABLET;ORAL	090084-001	Mar 22, 2011		DISCN	No	No
Sun Pharm Industries	OXYCODONE AND ASPIRIN	aspirin; oxycodone hydrochloride; oxycodone terephthalate	TABLET;ORAL	040260-001	Jul 17, 1998		DISCN	No	No
Roxane	OXYCODONE AND ASPIRIN (HALF-STRENGTH)	aspirin; oxycodone hydrochloride; oxycodone terephthalate	TABLET;ORAL	087742-001	Jun 4, 1982		DISCN	No	No
Roxane	ROXIPRIN	aspirin; oxycodone hydrochloride; oxycodone terephthalate	TABLET;ORAL	087743-001	Jun 4, 1982		DISCN	No	No
Epic Pharma Llc	OXYCODONE AND ASPIRIN	aspirin; oxycodone hydrochloride	TABLET;ORAL	040910-001	Jul 16, 2020	AA	RX	No	No

ASPIRIN; OXYCODONE HYDROCHLORIDE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Aspirin and Oxycodone Hydrochloride

Introduction

The pharmaceutical market is witnessing significant growth driven by increasing health awareness, rising prevalence of chronic diseases, and advancements in pharmaceutical formulations. This article delves into the market dynamics and financial trajectory of two pivotal drugs: aspirin and oxycodone hydrochloride.

Aspirin Market Dynamics

Global Market Size and Growth

The global aspirin market is substantial, with an estimated size of USD 2514.5 million in 2024. This market is expected to grow at a Compound Annual Growth Rate (CAGR) of 3.20% from 2024 to 2031, reaching USD 3134.8 million by 2031[1].

Regional Market Share

• North America: Holds the largest market share, accounting for over 40% of the global revenue with a market size of USD 1005.8 million in 2024. It is expected to grow at a CAGR of 1.4% from 2024 to 2031[1].
• Europe: Accounts for more than 30% of the global revenue, with a market size of USD 754.35 million in 2024, and is expected to grow at a CAGR of 1.7% from 2024 to 2031[1].
• Asia Pacific: Holds around 23% of the global revenue, with a market size of USD 578.34 million in 2024, and is expected to grow at a CAGR of 5.2% from 2024 to 2031[1].

Drivers of Growth

• Cardiovascular Health: The rising prevalence of cardiovascular diseases is a significant driver, as aspirin is often prescribed for its anti-thrombotic properties to prevent heart attacks and strokes[1][4].
• Pain Management: Aspirin's analgesic and anti-inflammatory properties make it a popular choice for managing pain and reducing fever[4].
• Pharmaceutical Innovations: Continuous innovations in dosage forms and delivery systems are expected to boost the market[4].

Oxycodone Hydrochloride Market Dynamics

Global Market Size and Growth

The global oxycodone hydrochloride market was valued at USD 401.6 million in 2023 and is projected to reach USD 578.9 million by 2031, growing at a CAGR of 4.7% from 2024 to 2031[2].

Regional Market Share

• North America: Holds the largest market share globally, driven by the increased acceptance of oxycodone as a pain reliever and the rising incidence of chronic illnesses[3].
• Asia Pacific: Expected to witness significant growth due to the rising number of surgical procedures and the growing burden of chronic pain diseases. Countries like China and India are key regional revenue centers[3][5].

Drivers of Growth

• Chronic Pain Management: The growing burden of chronic diseases such as cancer, rheumatoid arthritis, and lower back pain drives the demand for oxycodone hydrochloride[3].
• Pharmaceutical Advancements: Improvements in pharmaceutical formulations, particularly long-acting and controlled-release forms, enhance patient compliance and pain management[3][5].
• Increasing Surgical Procedures: The rise in surgical procedures increases the need for oxycodone hydrochloride as an analgesic for post-operative pain[5].

Financial Trajectory for Aspirin

Revenue Projections

• The aspirin market is expected to grow from USD 2.47 billion in 2023 to USD 2.59 billion in 2024, with a CAGR of 4.9%. By 2028, the market is projected to reach USD 3.2 billion at a CAGR of 5.4%[4].

Regional Revenue

• North America: Expected to grow at a CAGR of 1.2% from 2024 to 2031, with the United States contributing significantly to this growth[1].
• Europe: Expected to grow at a CAGR of 1.7% from 2024 to 2031, with countries like Italy and Spain contributing to the regional growth[1].

Financial Trajectory for Oxycodone Hydrochloride

Revenue Projections

• The oxycodone hydrochloride market is expected to grow from USD 401.6 million in 2023 to USD 578.9 million by 2031, with a CAGR of 4.7%[2].
• The broader oxycodone drugs market is anticipated to grow from USD 5.46 billion in 2024 to USD 8.29 billion by 2032, exhibiting a CAGR of 5.4%[3].

Segmental Growth

• Long-Acting Segment: Held the largest market share in 2022 due to its benefits of improved compliance and convenience of less-frequent dosing intervals[3].
• Capsules Segment: Expected to register the highest CAGR during the forecast period due to high prevalence of severe pain among adults[3].

Market Trends and Opportunities

Aspirin Market Trends

• Combination Therapies: Research into combination therapies and personalized medicine approaches is expected to drive growth[4].
• Telemedicine and Self-Care: Increasing adoption of telemedicine and self-care practices is likely to influence market dynamics[4].

Oxycodone Hydrochloride Market Trends

• Controlled-Release Formulations: The controlled-release segment is slated to register the fastest CAGR due to its benefits in managing chronic pain[5].
• Generic Versions: The introduction of generic versions of oxycodone drugs will increase competitive rivalry in the market[3].

Challenges and Regulatory Environment

Aspirin Market Challenges

• Side Effects: Aspirin's potential side effects, such as gastrointestinal issues, can limit its use and impact market growth.
• Regulatory Scrutiny: Strict regulatory environments can affect the approval and marketing of new aspirin formulations.

Oxycodone Hydrochloride Market Challenges

• Opioid Crisis: The ongoing opioid crisis and stringent regulations on opioid medications can pose challenges to market growth.
• Side Effects and Abuse Potential: The risk of side effects and abuse associated with oxycodone hydrochloride necessitates careful prescribing and monitoring[3].

Key Takeaways

• The aspirin market is driven by cardiovascular health awareness and pain management needs, with a projected growth to USD 3.2 billion by 2028.
• The oxycodone hydrochloride market is fueled by the growing burden of chronic pain diseases and advancements in pharmaceutical formulations, with a projected growth to USD 578.9 million by 2031.
• Regional markets, particularly North America and Asia Pacific, play significant roles in the growth trajectories of both drugs.
• Innovations in dosage forms, combination therapies, and telemedicine are key trends influencing these markets.

FAQs

Q: What is the current market size of the global aspirin market?

The global aspirin market size is estimated at USD 2514.5 million in 2024[1].

Q: What is the expected CAGR for the oxycodone hydrochloride market from 2024 to 2031?

The oxycodone hydrochloride market is expected to grow at a CAGR of 4.7% from 2024 to 2031[2].

Q: Which region is expected to witness significant growth in the oxycodone hydrochloride market?

The Asia Pacific region is anticipated to witness significant growth due to the rising number of surgical procedures and the growing burden of chronic pain diseases[3][5].

Q: What are the key drivers of the aspirin market?

The key drivers include cardiovascular health awareness, pain management needs, and pharmaceutical innovations[1][4].

Q: How does the opioid crisis impact the oxycodone hydrochloride market?

The opioid crisis and associated regulatory scrutiny can pose challenges to market growth and necessitate careful prescribing and monitoring of oxycodone hydrochloride[3].

Sources

1. Cognitive Market Research - Global Aspirin Market Report 2024
2. Market Research Intellect - Oxycodone Hydrochloride Market Size and Projections
3. Polaris Market Research - Oxycodone Drugs Market Size, Growth Analysis Report, 2024-2032
4. The Business Research Company - Global Aspirin Market Report 2024
5. GlobeNewswire - Global Oxycodone Hydrochloride Market Size Scaling New Heights With $578.94 Million Projection by 2030 Showing a 4.66% CAGR